Literature DB >> 10180676

Economic transition and health transition: comparing China and Russia.

Y Liu1, K Rao, J Fei.   

Abstract

Drawing on experiences from China and Russia (the world's two largest transitional economies), this paper empirically examines the impact of economic reforms on health status. While China's overall health status continued to improve after the economic reform, Russia experienced a serious deterioration in its population health. The observed differences in health performance between China and Russia can be explained by the different impacts of economic reforms on three major socioeconomic determinants of health. Depending on whether or not the reform improves physical environment (as reflected in income level and nutritional status), social environment (including social stability and security system), and health care, we would observe either a positive or a negative net effect on health. Despite remarkable differences in overall health development, China and Russia share some common problems. Mental and social health problems such as suicides and alcohol poisoning have been on the rise in both countries. These problems were much more serious in Russia, where political and social instability was more pronounced, associated with Russia's relatively radical reform process. With their economies moving toward a free market system, health sectors in China and Russia are undergoing marketization, which has had serious detrimental effect on the public health services.

Entities:  

Mesh:

Year:  1998        PMID: 10180676     DOI: 10.1016/s0168-8510(98)00010-4

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  14 in total

1.  Public health reforms in Estonia: impact on the health of the population.

Authors:  Kaja Põlluste; Georg Männik; Runo Axelsson
Journal:  BMJ       Date:  2005-07-23

2.  Sleeping money: investigating the huge surpluses of social health insurance in China.

Authors:  JunQiang Liu; Tao Chen
Journal:  Int J Health Care Finance Econ       Date:  2013-10-02

3.  Changes and equity in use of maternal health care in China: from 1991 to 2003.

Authors:  Zhuochun Wu; Peng Lei; Elina Hemminki; Ling Xu; Shenglan Tang; Xiaoyan Li; Joanna Raven; Jun Gao; Rachel Tolhurst
Journal:  Matern Child Health J       Date:  2012-02

4.  Economic Security, Social Cohesion, and Depression Disparities in Post-transition Societies: A Comparison of Older Adults in China and Russia.

Authors:  Ning Hsieh
Journal:  J Health Soc Behav       Date:  2015-11-17

5.  High prevalence of hyperglycaemia and the impact of high household income in transforming rural China.

Authors:  Chaowei Fu; Yue Chen; Fadi Wang; Xuecai Wang; Jiangen Song; Qingwu Jiang
Journal:  BMC Public Health       Date:  2011-11-12       Impact factor: 3.295

Review 6.  The development and experience of epidemiological transition theory over four decades: a systematic review.

Authors:  Ailiana Santosa; Stig Wall; Edward Fottrell; Ulf Högberg; Peter Byass
Journal:  Glob Health Action       Date:  2014-05-15       Impact factor: 2.640

7.  Measuring financial protection for health in families with chronic conditions in Rural China.

Authors:  Chunhong Jiang; Jingdong Ma; Xiang Zhang; Wujin Luo
Journal:  BMC Public Health       Date:  2012-11-16       Impact factor: 3.295

8.  Disparities in Prevalence of Cardiometablic Risk Factors in Rural, Urban-Poor, and Urban-Middle Class Women in India.

Authors:  Indu Mohan; Rajeev Gupta; Anoop Misra; Krishna Kumar Sharma; Aachu Agrawal; Naval K Vikram; Vinita Sharma; Usha Shrivastava; Ravindra M Pandey
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

9.  From plan to market in the health sector?: China's experience.

Authors:  Karen Eggleston; Jian Wang; Keqin Rao
Journal:  J Asian Econ       Date:  2008-09-07

10.  Tackling the challenges to health equity in China.

Authors:  Shenglan Tang; Qingyue Meng; Lincoln Chen; Henk Bekedam; Tim Evans; Margaret Whitehead
Journal:  Lancet       Date:  2008-10-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.